U.S. Overdose Deaths Decrease in 2023

Health & Lifestyle
311

Listen to article (english)

Translate to Spanish or other 102 languages!

There were an estimated 107,543 overdose deaths in the United States in 2023, according to the CDC. 111,029 deaths were reported in 2022.  Image for illustration purposes
There were an estimated 107,543 overdose deaths in the United States in 2023, according to the CDC. 111,029 deaths were reported in 2022.  Image for illustration purposes

Mega Doctor News

- Advertisement -

Newswise — According to the Centers for Disease Control, preliminary data shows drug overdose deaths decreased by three percent in 2023. This would be the first annual decrease in drug overdose deaths since 2018. 

There were an estimated 107,543 overdose deaths in the United States in 2023, according to the CDC. 111,029 deaths were reported in 2022. 

Nebraska, Kansas, Indiana and Maine saw decreases of more than 15 percent. 

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Pioneering gene therapy restores deaf toddler’s hearing
Next article
Surprising Health Benefits of Pickles

More Articles

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen. FULL TO CAPACITY. NO MORE ROOM.

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

The Connection Between Diet and Breast Cancer Risk

October is Breast Cancer Awareness Month, and many people may be wondering how to lower their risk.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Simple Steps to Soothe Arthritis Pain

Mega Doctor News CLEVELAND CLINIC - Osteoarthritis is the most common form of...
- Advertisement -